Why this is a women's disease

Graves' disease is an autoimmune disorder in which antibodies (TRAK / TRAb / TSI) bind to the TSH receptor and drive the thyroid into overdrive β€” too much T3 and T4. It is the most common cause of hyperthyroidism, and it overwhelmingly affects women. A woman's lifetime risk is roughly 3%, versus about 0.5% for men β€” a 5–8Γ— imbalance driven by estrogen effects on the immune system, X-chromosome genetics, and reproductive transitions (pregnancy, postpartum, menopause).

In plain terms. The thyroid is a small butterfly-shaped gland in the front of the neck. It acts like the body's thermostat β€” it sets how fast everything runs: heart rate, body temperature, energy use, mood, digestion. In Graves', the immune system makes a mistake and produces an antibody that latches onto the thyroid and jams the accelerator down. The thyroid can't tell the difference, so it keeps pumping out hormone. The body runs hot and fast: racing heart, weight loss without trying, trembling hands, feeling warm when others feel cold, trouble sleeping, anxiety, tired-but-wired. It's not caused by stress, diet, or anything the person did β€” it's the immune system misfiring. It's also the most common cause of an overactive thyroid, well understood, and treatable: medication (which calms the thyroid down while the immune system settles), radioactive iodine, or surgery. Most people get back to a normal life; many go into long-term remission.
TRH TSH Iodine (I⁻) T3 / T4 (and TRAK in Graves') Negative feedback

Want the prevalence numbers, age-of-onset curves, and women-vs-men comparisons? Head over to the Statistics tab.

Graves' by the numbers

Who gets Graves', when, and how often β€” the headline epidemiology.

~3% Lifetime risk in women vs ~0.5% in men
5–8Γ— More common in women than men driven by estrogen, X-chromosome, reproductive transitions
37.9Annual incidence per 100,000 women
20–50Peak age of onset (years)
1–4 / 1,000Pregnancies affected (US)
~40%Postpartum relapse within 1 yr

Compare your labs to the dataset

Enter your thyroid panel and see where it lands against ~9,100 patients in the UCI reference dataset. Saved locally in your browser β€” nothing uploaded.

Not a diagnostic tool. The UCI data is from one institution in the 1980s β€” useful as a reference distribution, not a clinical decision aid. Reference ranges shown are typical lab ranges; your own lab's ranges may differ.

Your entry

Sex
Advanced labs (UCI dataset) β€” T4U & FTI

T4U (T4 uptake) and FTI (free T4 index) are older calculated indices used in the UCI dataset. Most modern labs report FT4 directly instead β€” skip these if you don't have them.

Leave any lab blank if you don't have it β€” only entered values are compared.

Your saved entries

No entries yet β€” fill in the form to log your first.

DateTSHT3TT4FTI

TRAK statistics

How well TRAK performs as a diagnostic, and how its level predicts relapse after antithyroid drugs.

Diagnostic performance (cutoff 1.75 IU/L)

3rd-gen assays: sensitivity ~97%, specificity ~99%.

TRAK level β†’ relapse risk after ATD

Pregnancy statistics

Risks of untreated maternal Graves' and the postpartum relapse curve.

Risks of untreated maternal hyperthyroidism

Cumulative postpartum relapse risk

Real data β€” women only

Filtered to female records from the UCI thyroid dataset (n=1,830 women, 64 with hyperthyroid-spectrum diagnoses).

Age at onset in women

Strong peak at 50–59 with substantial cases through reproductive years and into the postmenopausal period.

Diagnosis breakdown β€” women

More charts β€” incidence by life stage & women vs men

Incidence by life stage (per 100,000 women/year)

Women vs men β€” lifetime risk

πŸ› οΈ
Developer & data tools
Schema, command-line recipes, and bulk dataset downloads. Skip this section if you're not analyzing raw data.

Reading the datasets

Column schema and copy-paste shell / Python recipes for the UCI Garavan thyroid files.

Files in ./datasets/ are comma-separated, no header row, with ? for missing values and the diagnosis appended as label.|recordID.

Column schema (allhyper.data, allbp.data)

#FieldValues
1agecontinuous (years)
2sexM / F / ?
3–16flagson thyroxine, query on thyroxine, on antithyroid medication, sick, pregnant, thyroid surgery, I131 treatment, query hypothyroid, query hyperthyroid, lithium, goitre, tumor, hypopituitary, psych β€” each t/f
17–18TSH measured / TSHt/f and continuous (mU/L)
19–20T3 measured / T3t/f and continuous (nmol/L)
21–22TT4 measured / TT4t/f and continuous (nmol/L)
23–24T4U measured / T4Ut/f and ratio
25–26FTI measured / FTIt/f and continuous (free thyroxine index)
27–28TBG measured / TBGt/f and continuous
29referral sourceWEST / STMW / SVHC / SVI / SVHD / other
30diagnosishyperthyroid / T3 toxic / goitre / secondary toxic / negative

Quick reads β€” copy-paste recipes

Inspect first 5 rows:

head -5 datasets/allhyper.data

Count diagnosis classes:

awk -F',' '{print $NF}' datasets/allhyper.data \
  | awk -F'.' '{print $1}' | sort | uniq -c

Female-only hyperthyroid cases:

awk -F',' '$2=="F" && $NF !~ /negative/' \
  datasets/allhyper.data

Load in Python (pandas):

import pandas as pd
cols = ['age','sex','on_thyroxine','query_thyroxine',
        'on_antithyroid','sick','pregnant','surgery',
        'I131','q_hypo','q_hyper','lithium','goitre',
        'tumor','hypopit','psych',
        'TSH_m','TSH','T3_m','T3','TT4_m','TT4',
        'T4U_m','T4U','FTI_m','FTI','TBG_m','TBG',
        'referral','diagnosis']
df = pd.read_csv('datasets/allhyper.data',
                 names=cols, na_values='?')
df['diagnosis'] = df['diagnosis'].str.split('.').str[0]
df[df.sex=='F'].diagnosis.value_counts()
Tip: The last column actually looks like negative.|3733 β€” the part after | is the record ID, useful for joining across the Garavan files but not for analysis.

Causes β€” why me?

Graves' isn't caused by any single thing. It's a perfect storm: a genetic predisposition that primes the immune system, plus a trigger that tips it into producing the TRAK antibody. Most of the predisposition is unchangeable. Some of the triggers are.

Predisposition (unchangeable)
+
Trigger (sometimes modifiable)
β†’
Immune system makes TRAK antibody β†’ Graves'

Predisposition β€” can't change

♀️
Female sex
5–8Γ— higher lifetime risk than men β€” estrogen effects on immunity + X-chromosome genetics.
🧬
Family history
Graves', Hashimoto's, T1D, vitiligo, or other autoimmune disease in close relatives raises risk substantially.
πŸ”¬
Specific gene variants
HLA-DR3, CTLA-4, CD40, PTPN22 β€” none deterministic, but they shift the baseline.
πŸ”—
Existing autoimmune disease
If you have T1D, celiac, vitiligo, or RA β€” your immune system has already shown it can misfire.

Triggers β€” sometimes modifiable

🀱
Postpartum (0–12 months)
The single biggest hormonal trigger in women. Immune rebound after the pregnancy "tolerance" state.
🚬
Smoking
~2Γ— the risk of Graves' overall, and the strongest modifiable risk for the eye disease (orbitopathy).
😰
Severe stress / major life events
Bereavement, divorce, severe illness β€” implicated in ~30% of new diagnoses and relapses.
🦠
Viral infections
EBV, retroviruses, and now SARS-CoV-2 have been linked to triggering autoimmune thyroid disease.
πŸ§‚
Excess iodine
Kelp, iodine supplements, iodinated contrast can unmask Graves' in a predisposed person.
β˜€οΈ
Vitamin D deficiency
Low D is more common in Graves' patients; whether it's cause or consequence isn't fully settled.
It is not your fault. No diet, lifestyle choice, or "thing you should have done differently" causes Graves' on its own. The autoimmune misfire is the core problem; triggers just decide when a predisposed immune system tips over.

The female life course

Graves' interacts with every major reproductive transition. The shape below is the relative incidence across a woman's life β€” a peak in the reproductive years, a second peak around menopause. Hover or tap any pin to see what changes at that stage.

Relative incidence 10 20 30 40 50 60 Age 1 2 3 4 5 6 Peak onset 2nd peak
1
Puberty / teens
Rare but possible. Easily mistaken for anxiety, eating disorder, or stress.
2
Reproductive years
Peak onset window. Anovulatory cycles, subfertility. Treatment usually restores cycles.
3
Pregnancy β€” 1st trimester
hCG may unmask Graves'. PTU preferred over methimazole.
4
Pregnancy β€” 2nd / 3rd
TRAK often falls. Switch from PTU to methimazole after week 16. RAI contraindicated.
5
Postpartum (0–12 mo)
~40% of women in remission relapse here. Differentiate from postpartum thyroiditis.
6
Perimenopause / menopause
Second peak. Hot flashes & palpitations can mask Graves' β€” check TSH if atypical.

Symptoms women notice first

Graves' touches almost every system in the body. Symptoms below are ranked by how common they are in women with active disease (approximate, from clinical literature β€” varies by age and severity). Hover any bar to see more detail.

1
πŸ’“ Racing heart / palpitations
~85%
Tachycardia, palpitations, A-fib
2
πŸ₯΅ Heat intolerance
~80%
Sweating, flushing β€” mimics perimenopause
3
βš–οΈ Weight loss
~75%
Despite increased appetite
4
😰 Anxiety / insomnia
~72%
Often the presenting complaint in young women
5
😬 Hand tremor
~70%
Fine tremor visible with arms extended
6
πŸ“‰ Irregular periods
~65%
Light, infrequent, or absent menstruation
7
πŸ’‡ Hair thinning
~50%
Diffuse hair loss, brittle nails
8
πŸ’ͺ Muscle weakness
~45%
Stairs, getting up from chairs
9
πŸ¦‹ Visible goiter
~40%
Front-of-neck swelling
10
πŸ‘οΈ Eye changes
25–50%
Bulging, dryness, double vision (orbitopathy)
11
🀰 Difficulty conceiving
~25%
Anovulation; miscarriage risk
12
🦴 Bone loss
~20%
Accelerated osteoporosis β€” esp. post-menopause

How it's diagnosed

Diagnosis follows a defined sequence: confirm hyperthyroidism with thyroid hormone labs, then confirm Graves' as the cause (rather than a toxic nodule or thyroiditis) with antibodies and/or imaging.

1
Suspect from symptoms
Racing heart, weight loss, heat intolerance, anxiety, tremor, irregular periods. Often picked up by a GP first.
β–Ό
2
TSH β€” the first screening test
Very sensitive. Low (often < 0.01 mIU/L) suggests hyperthyroidism. Normal TSH essentially rules it out.
β–Ό
3
FT4 and FT3 β€” confirm hyperthyroidism
Both elevated β†’ overt hyperthyroidism. FT4 normal but FT3 elevated β†’ "T3 toxicosis," common early in Graves'.
β–Ό
4
TRAK / TRAb β€” confirms Graves' specifically
Positive in ~97% of Graves' cases. Specificity ~99%. A positive TRAK with low TSH and high FT4 is essentially diagnostic β€” no imaging needed.
β–Ό
5
Imaging β€” only if TRAK negative or borderline
Thyroid ultrasound (preferred in pregnancy / women planning to conceive) shows diffuse enlargement and increased vascularity. Radioactive iodine uptake (RAIU) shows high diffuse uptake in Graves' vs focal hot spot in toxic nodule vs low in thyroiditis. Contraindicated in pregnancy.

Differential diagnosis β€” Graves' vs other causes of hyperthyroidism

CauseTRAKRAIU patternCourse
Graves' diseasePositiveHigh, diffusePersistent without treatment
Toxic nodular goiterNegativeFocal hot spot(s)Persistent; surgery / RAI
Subacute thyroiditis (de Quervain's)NegativeLowPainful neck; self-limited (weeks)
Postpartum thyroiditisNegativeLowSelf-limited (months)
Factitious (exogenous T4)NegativeLowHistory of thyroid hormone intake
If you're newly diagnosed. Ask for your actual numbers β€” TSH, FT4, FT3, TRAK. Knowing where you started is the only way to track whether treatment is working. The TRAK section on the Treatment tab explains how to interpret your level.

Course over time β€” what to expect

Graves' is a chronic condition with several possible long-term paths. The trajectory depends mostly on which treatment is chosen and how the immune system behaves after β€” relapse is common in the first 5 years, and a subset of people eventually drift into hypothyroidism even without RAI or surgery.

Untreated
  • Continued hyperthyroidism, worsening symptoms
  • Risks: A-fib, heart failure, osteoporosis, thyroid storm
  • Spontaneous remission is rare (< 5%)
  • Eye disease can progress independently
Antithyroid drugs (12–18 mo)
  • Symptoms improve within 2–6 weeks
  • FT4 normalizes in weeks; TSH lags 6–8 weeks behind
  • ~40–50% in remission at end of course
  • ~50% relapse within 5 years (highest in first year)
  • High TRAK at stop β†’ high relapse risk
Radioactive iodine (RAI)
  • ~90–95% definitive cure of hyperthyroidism
  • Most become hypothyroid within 6–12 months
  • Lifelong levothyroxine, simple to manage
  • Can worsen eye disease (esp. in smokers)
  • No pregnancy for β‰₯ 6 months after
Thyroidectomy (surgery)
  • ~99% definitive β€” fastest control
  • Hypothyroid immediately; start levothyroxine
  • Risks: hypoparathyroidism (~1–2%), nerve injury (~1%)
  • Preferred if planning pregnancy soon, severe eye disease, or large goiter

Common long-term patterns

The relapse window

After an ATD course, relapse risk is highest in the first year and decreases over time. Most relapses happen within 5 years; after 10 years of remission, relapse becomes uncommon. Postpartum is its own distinct relapse window β€” see the Pregnancy tab.

"Burnout" to hypothyroidism

A subset of people on ATD eventually drift into hypothyroidism as the gland fibroses from chronic autoimmune attack. This isn't a treatment failure β€” it's natural history. They transition to levothyroxine, the same endpoint as RAI or surgery but slower.

Pregnancy & Graves'

Roughly 1–4 in 1,000 pregnancies are complicated by Graves'. Untreated, maternal hyperthyroidism raises the risk of miscarriage, pre-eclampsia, preterm birth, low birth weight, stillbirth, and fetal/neonatal thyroid problems. Treated well, outcomes are close to normal.

For drug choices and trimester-by-trimester management, see the Treatment in pregnancy section on the Treatment tab. This page focuses on what to watch for β€” fetal/neonatal effects, the thyroid-storm emergency, and the postpartum relapse window.

Risk timeline β€” what to watch for, when

1st trimester 2nd trimester 3rd trimester Labor Postpartum 0w 13w 27w 40w 6m 12m Miscarriage risk if untreated; switch MMIβ†’PTUMMI (methimazole) is the default antithyroid drug outside pregnancy. PTU (propylthiouracil) replaces it in the first trimester because it has a lower risk of birth defects in weeks 6–10. TRAK recheck 18–22w fetal monitoring if > 3Γ— ULN Growth + fetal HR low-dose ATD, aim upper-third FT4ATD = antithyroid drug (methimazole or PTU). High-dose ATD crosses the placenta and can cause fetal hypothyroidism, so the goal in the third trimester is the lowest effective dose with maternal FT4 in the upper third of the normal range. ⚠ Thyroid storm risk Relapse window ~1 in 3 relapses ≀ 12 mo Re-check labs TSH, FT4, TRAK at 6w & 6mo

Fetal & neonatal effects

Four possible problems β€” two driven by maternal TRAK crossing the placenta, two driven by maternal antithyroid drugs crossing the placenta.

πŸ‘ΆFetal hyperthyroidismTRAK
Maternal TRAK crosses placenta β†’ stimulates fetal thyroid
Watch for: fetal tachycardia (> 160 bpm), poor growth, goiter on ultrasound, advanced bone age
πŸ‘ΆFetal hypothyroidismATD
Excess maternal antithyroid drug crosses placenta
Watch for: fetal bradycardia, goiter, growth restriction
🍼Neonatal hyperthyroidismTRAK
TRAK persists in baby's blood for weeks after birth
Watch for: tachycardia, irritability, poor feeding, weight loss β†’ cord blood + day-3 labs
🍼Neonatal hypothyroidismATD
Residual maternal antithyroid drug in baby
Watch for: newborn TSH screen catches it; usually self-resolves in days

Thyroid storm in pregnancy

25%mortality if untreated
A true obstetric emergency. Most often triggered by labor itself, infection, surgery, or abrupt drug stop. Treat fast; deliver if mother becomes unstable.
⚠ Signs
  • High fever
  • Severe tachycardia (> 140)
  • Agitation / altered mental status
  • Heart failure
πŸ”₯ Triggers
  • Labor & delivery
  • Infection
  • Surgery
  • Abrupt antithyroid drug stop
πŸ’‰ Treatment
PTU / methimazole Iodine Beta-blocker Steroid Supportive care
Deliver if mother is unstable.

Postpartum β€” the relapse window

New hyperthyroid symptoms in the first 12 months postpartum are common and split into two very different conditions β€” they look similar but the treatment and prognosis diverge sharply.

Postpartum thyroiditisSelf-limited
  • TRAKNegative
  • RAIU uptakeLow
  • CourseResolves in months
  • TreatmentBeta-blocker only
vs
Graves' relapsePersistent
  • TRAKPositive
  • RAIU uptakeHigh, diffuse
  • CoursePersistent without Rx
  • TreatmentATD or definitive (RAI / surgery)
Cumulative postpartum relapse risk over 24 months is plotted on the Statistics tab.

Where to start

Pick the situation that fits β€” it'll take you to the section you need first.

Medical treatment

Three disease-modifying options. None is best for everyone β€” the choice depends on age, pregnancy plans, severity, eye involvement, and your own preference.

Beta-blockers control symptoms but don't treat the disease.

πŸ“–
Acronyms used in this section.
  • ATD β€” antithyroid drug. The drug class that blocks the thyroid from making new hormone. In Graves' management this means one of two drugs: MMI or PTU. "ATD therapy" = the drug route, as opposed to RAI (radioactive iodine) or surgery.
  • MMI β€” methimazole (also called thiamazole; brand names Tapazole, Thacapzol). The default ATD outside pregnancy: more potent than PTU, once-daily dosing, lower liver-injury risk. Carbimazole (used in Europe/UK) is a prodrug the body converts to methimazole β€” same drug for clinical purposes.
  • PTU β€” propylthiouracil. The other ATD. Preferred in the first trimester of pregnancy (lower embryopathy risk than methimazole) and in thyroid storm. Carries an FDA black-box warning for rare severe liver injury, so it's not first-line outside those situations.
  • RAI β€” radioactive iodine (I-131). A definitive treatment that destroys overactive thyroid tissue.
  • FT4 / TSH / TRAK β€” the lab values that drive every treatment decision; see the Labs & monitoring section.
πŸ’Š
Antithyroid drugs (ATD)
~40–50% remission
How it worksMethimazole (or PTU) blocks the thyroid from making T3/T4
Time to effectSymptoms improve in 2–6 weeks; FT4 normalizes in weeks; TSH lags 6–8 weeks
Duration12–18 month course, then attempt stop
Reversible?Yes β€” preserves thyroid
Main risksRash (~5%), liver injury, agranulocytosis (rare but serious)
Best forMild–moderate disease, planning pregnancy, eye disease, first-line in most women
☒️
Radioactive iodine (RAI)
~90–95% cure
How it worksOral I-131 capsule destroys overactive thyroid cells
Time to effectWeeks to months; most become hypothyroid within 6–12 months
DurationSingle dose (sometimes repeat); lifelong levothyroxine after
Reversible?No β€” permanent
Main risksCan worsen eye disease (esp. in smokers); permanent hypothyroidism
Female notesContraindicated in pregnancy & breastfeeding. Wait β‰₯ 6 months before conceiving.
πŸ”ͺ
Thyroidectomy (surgery)
~99% definitive
How it worksTotal or near-total surgical removal of the thyroid
Time to effectHypothyroid immediately; start levothyroxine the next day
DurationOne-time procedure; lifelong levothyroxine after
Reversible?No β€” permanent
Main risksHypoparathyroidism (~1–2%), nerve injury (~1%), surgical risks
Best forLarge goiter, severe eye disease, drug-intolerant, planning pregnancy soon
❀️
Beta-blockers (propranolol, atenolol) β€” supportive only. Bring down heart rate, tremor, anxiety while disease-modifying treatment kicks in. Propranolol is safe at low doses in pregnancy. Not a treatment for Graves' itself.

Success rates at a glance

TRAK β€” your lab result

The single most useful number for predicting how the disease will behave and when you can stop antithyroid drugs.

TRAK (German TSH-Rezeptor-AntikΓΆrper; English TRAb / TSI) is the autoantibody that drives Graves' β€” it activates the TSH receptor on the thyroid and causes the disease.

TRAK level (IU/L) 0 1.75 5 12 40+ Negative Low positive Moderate High β€” severe healthy early / mild active disease relapse-prone, fetal-risk

What your band predicts

Approximate relapse risk after a standard 12–18 month antithyroid drug course, based on TRAK level at the end of treatment.

Negative / Low+
~20–30%
Best prognosis. Often the green light to taper or stop antithyroid drugs.
Moderate
~50%
Coin-flip relapse risk. Most endocrinologists continue ATD or consider definitive treatment.
High
~70–80%
High relapse risk. Often steers the decision toward surgery or RAI rather than another ATD course.
Pregnancy threshold. TRAK is IgG and crosses the placenta β€” even a mother who's euthyroid after RAI or surgery can cause fetal or neonatal hyperthyroidism. Values above 3Γ— the upper limit of normal in pregnancy trigger fetal monitoring (heart rate, growth ultrasound, TRAK at 18–22 weeks).
When to re-check. At diagnosis Β· before stopping antithyroid drugs Β· early pregnancy and again at 18–22 weeks if elevated Β· if relapse is suspected. Don't re-check more often than every 6–8 weeks during a drug change β€” antibody levels move slowly.

Treatment in pregnancy & breastfeeding

Pregnancy changes almost every treatment decision. Methimazole becomes risky in the first trimester; radioactive iodine is off the table entirely; some supplements need to be re-thought.

The full epidemiology, fetal/neonatal considerations, and postpartum relapse window live on the Pregnancy tab β€” this section focuses on what to do.

Pre-conception planning

Ideally, achieve a stable euthyroid state before conception. Choices:

  • On antithyroid drugs, controlled? Two accepted paths β€” decide with the endocrinologist before stopping contraception:
    • Pre-conception switch to PTU. Safest if conception may happen quickly β€” no window where an unrecognized early pregnancy (weeks 4–6) gets methimazole.
    • Stay on methimazole, switch at first positive test. Limits PTU liver exposure, but only works if she tests early and the switch happens within days β€” the teratogenic window (weeks 6–10) comes up fast.
  • In remission, off drugs for β‰₯ 1 year? No PTU needed β€” but remission β‰  cure. TRAK antibodies can persist and cross the placenta regardless of maternal thyroid status. Required:
    • TRAK measured pre-conception and again at 18–22 weeks. If > 3Γ— ULN, fetal monitoring (heart rate, growth, goiter on US) is indicated even if mom is euthyroid.
    • TSH / FT4 through pregnancy β€” relapse risk is elevated, especially postpartum (up to ~50% in the first year).
  • TRAK very high (>5Γ— ULN) or large goiter? Consider definitive therapy (surgery preferred over RAI if planning pregnancy soon) 6+ months before trying β€” removes the drug question entirely.
  • If RAI: wait at least 6 months and confirm euthyroid before trying.
  • Already pregnant on methimazole? Switch to PTU urgently in 1st trimester (lower teratogenic risk).

Trimester-by-trimester management

StagePreferred drugMonitoringAvoid
1st trimester (0–13w) PTU 50–300 mg/day FT4 every 2–4 weeks; aim for upper third of normal Methimazole (aplasia cutis, choanal atresia), RAI
2nd trimester (14–27w) Switch to methimazole 5–15 mg/day (lower liver risk) FT4 every 4 weeks; TRAK at 18–22w if previously high RAI
3rd trimester (28–40w) Methimazole, often at lowest effective dose FT4; fetal heart rate, growth ultrasounds; TRAK RAI; high-dose ATDs (fetal hypothyroidism)
Labor & delivery Continue ATD; watch for thyroid storm trigger (infection, stress) Maternal HR, BP, T; cord blood TSH/FT4 + TRAK Iodinated contrast unless absolutely needed
Breastfeeding Methimazole ≤ 20 mg/day or PTU ≤ 450 mg/day Take dose after feeds; monitor infant TSH if mom on high dose RAI scanning/treatment

Off the table during pregnancy

β›” Radioactive iodine
Crosses the placenta, destroys fetal thyroid. Wait β‰₯ 6 months after RAI before conceiving.
β›” High-dose iodine / contrast
Iodinated CT contrast and high-iodine supplements can cause fetal hypothyroidism & goiter.
β›” High-dose ATD
Crosses the placenta β€” use lowest effective dose, aim for upper-third FT4 to protect the fetus from over-treatment.
β›” Abrupt drug stop
Risks thyroid storm at labor β€” an obstetric emergency with up to 25% mortality untreated.
Natural / lifestyle during pregnancy β€” what stays safe & what to re-think

What stays safe

β˜€οΈ
Vitamin D
Keep at > 30 ng/mL through pregnancy & nursing β€” standard prenatal guidance.
🐟
Omega-3 (DHA)
Good for fetal brain development; choose low-mercury sources or purified supplements.
🧘
Stress reduction
Postpartum is a major relapse window β€” yoga, breathwork, CBT, social support all matter.
😴
Sleep
Hard with a newborn, but protected sleep windows blunt the postpartum relapse risk.
🚭
No smoking
Strongest modifiable risk for Graves' eye disease β€” and obvious fetal harm.
🚢
Gentle exercise
Walking, prenatal yoga, swimming β€” once heart rate is controlled.

What to re-think

ItemReason to pause
Selenium supplementsHelpful for mild eye disease outside pregnancy β€” but doses > 200 Β΅g/day not well-studied in pregnancy. Discuss with your endocrinologist.
L-carnitineLimited pregnancy safety data. Skip unless your doctor specifically recommends it.
High-iodine kelp/seaweedExcess iodine can flip the fetal thyroid into hypothyroidism. Keep iodine to the prenatal RDA (~220 Β΅g).
"Thyroid support" herbal blendsOften contain undeclared iodine, ashwagandha, or thyroid extract. Avoid entirely.
High caffeineCompounds tachycardia & insomnia; also limited per general pregnancy guidance (< 200 mg/day).
Strict elimination dietsRisk of under-nutrition during pregnancy. Only restrict with a clear medical reason (e.g., confirmed celiac).
If you're planning pregnancy: get to a stable euthyroid state first, choose a treatment path with your endocrinologist that accounts for the next 12–18 months (ATDs vs. definitive treatment with surgery), and confirm baseline TRAK β€” high TRAK predicts fetal/neonatal risk even if mom is euthyroid.
Postpartum: Graves' relapses in roughly 1 in 3 women within 12 months of delivery, often masked as "new-mom" fatigue or anxiety. Re-check TSH, FT4, and TRAK at 6 weeks and 6 months postpartum β€” even if you felt fine through pregnancy.

What to ask your doctor & follow-ups

Questions for each visit, the labs that matter, and the symptoms that mean "call today, don't wait."

TSH lags weeks behind your symptoms, antibodies wax and wane, and antithyroid drugs have their own risks. Going in with a list and tracking your own numbers between visits makes a real difference.

At diagnosis / before choosing treatment

  • What is my TRAK / TRAb level, and what does the magnitude mean for my prognosis?
  • Are my TPO and thyroglobulin antibodies also positive? (overlap with Hashimoto's)
  • What's my TSH, FT4, FT3 β€” and how far outside reference are they?
  • Is there a goiter or nodule? Do I need a thyroid ultrasound or RAIU scan?
  • Any signs of eye involvement? Should I see an ophthalmologist familiar with Graves' orbitopathy?
  • Given my age & pregnancy plans, which treatment fits β€” ATD vs RAI vs surgery?
  • Baseline DEXA (bone density), ECG, and vitamin D?
  • What's my plan if I get pregnant on treatment?

At each follow-up visit

  • What are my latest TSH / FT4 / FT3 β€” and what's the trend vs last visit?
  • Is my TRAK rising or falling? (especially before stopping ATD)
  • Any change to drug dose? When's the next blood draw?
  • If on ATD: when is my next CBC and LFT? Any new bruising, sore throat, or jaundice?
  • How are my heart rate, weight, sleep, periods, mood?
  • If post-RAI / surgery: am I on the right levothyroxine dose?
  • Are we close to the point where I can try to stop ATD? What does my TRAK say?
  • Any updates I should know on guidelines or new options (e.g., teprotumumab for eye disease)?

Labs to track β€” the core thyroid panel

🩸TSH
Pituitary feedback. Lags 6–8 weeks behind treatment changes β€” don't over-interpret early.
Every 4–6 wks during active disease; every 3–6 mo once stable
🩸FT4 (free T4)
The active hormone you actually feel. The number to follow during dose changes.
Every 4–6 wks during titration
🩸FT3 (free T3)
Catches T3 toxicosis β€” symptoms persist while FT4 looks normal.
If FT4 normal but symptoms continue; at diagnosis
🎯TRAK / TRAb
The Graves'-specific antibody. Disease activity marker. Predicts relapse & fetal risk.
At dx; before stopping ATD; early pregnancy + 18–22 wks if elevated; if relapse suspected
πŸ§ͺTPO antibody
Hashimoto overlap. Affects long-term thyroid behavior after Graves' burns out.
Once at diagnosis
πŸ§ͺTg antibody
Thyroglobulin antibody β€” adds context for autoimmune overlap.
Once at diagnosis
Beyond thyroid β€” values that matter for women on Graves' (show all)
⚠️CBC (white count)Agranulocytosis
Rare but serious ATD side effect. Stop drug + call doctor if febrile or sore throat.
Baseline; any febrile illness on ATD
⚠️ALT / AST (LFTs)Hepatotoxicity
Liver injury risk β€” especially PTU. Methimazole can also affect liver.
Baseline; every 1–3 months on ATD; if jaundice / nausea
β˜€οΈVitamin D (25-OH)
Often low in Graves'; supports immune balance & bone.
Annually; aim > 30 ng/mL
🩸Ferritin / B12
Fatigue and hair loss have many causes β€” rule out non-thyroid contributors.
If symptoms persist after euthyroid
🦴Calcium & PTH
Post-thyroidectomy hypoparathyroidism risk; baseline bone health.
Day 1, week 1, month 1 post-surgery; annually if osteoporosis
🦴DEXA (bone density)
Long-standing hyperthyroidism accelerates bone loss β€” major issue post-menopause.
Baseline if post-menopausal or prolonged hyper; repeat every 1–2 yrs
πŸ’“ECG
Screen for atrial fibrillation β€” increased risk during active disease.
At diagnosis; if palpitations or age > 50
πŸ“ŠLipid panel
Hyperthyroidism lowers cholesterol; hypothyroidism (post-RAI) raises it.
Baseline & annually
🀰HCG (pregnancy test)
Before any RAI scan/treatment. Period changes can mask pregnancy.
Before RAI; if cycles irregular

Call your doctor the same day if

πŸ€’
Fever + sore throat while on antithyroid drug
Possible agranulocytosis β€” stop the drug, get a CBC same day.
🟑
Yellowing of skin or eyes, severe nausea
Possible drug-induced liver toxicity β€” stop the drug, get LFTs.
πŸ’”
Severe palpitations, chest pain, or new irregular heartbeat
Possible atrial fibrillation or thyrotoxic heart failure.
πŸ‘οΈ
New double vision, eye pain, or vision loss
Possible active Graves' orbitopathy β€” needs urgent ophthalmology review.
🚨
Confusion, high fever, severe vomiting
Possible thyroid storm β€” call emergency services. Up to 25% mortality if untreated.
Self-tracking tip: Keep a simple spreadsheet β€” date, TSH, FT4, FT3, TRAK, drug dose, resting heart rate, weight, period date. Bring it to every visit. Trends matter more than any single reading.

Natural remedies & lifestyle

Adjuncts only β€” these don't replace antithyroid drugs, RAI, or surgery. But three of them have strong enough evidence to matter.

Bottom line β€” the three highest-evidence moves

🚭
Stop smoking
Halves the progression of Graves' eye disease. Single biggest modifiable risk.
πŸ§‚
Limit iodine to dietary RDA
Skip kelp, seaweed snacks, iodine supplements, "thyroid support" blends. Keep iodine ~150 Β΅g/day.
🌿
Selenium if mild eye disease
100–200 Β΅g/day for 6 months. RCT-supported for mild Graves' orbitopathy (EUGOGO trial).
Supplements with evidence β€” show all
🌿
Selenium 100–200 Β΅g/day
Best evidence for mild Graves' ophthalmopathy β€” EUGOGO trial. 6-month course.
β˜€οΈ
Vitamin D
Deficiency common in Graves'. Correct to > 30 ng/mL β€” may modestly support remission & bone.
🐟
Omega-3 (EPA/DHA)
Anti-inflammatory; may help mood, joint aches, and dry eyes.
πŸ’Ž
Magnesium & B-vitamins
Often depleted in hyperthyroidism. Help with palpitations, fatigue, sleep.
🦴
Calcium 1000–1200 mg + Vit K2
Especially post-menopause β€” counters Graves'-driven bone loss.
βš–οΈ
L-carnitine 2–4 g/day
Small trials show reduced palpitations & tremor as ATD adjunct. Talk to doctor first.
Lifestyle changes that move the needle β€” show all
🧘
Stress reduction
Major life stress precedes ~30% of Graves' onset and relapses. Yoga, meditation, CBT, breathwork.
😴
Sleep 7–9 h
Poor sleep raises cortisol and worsens autoimmunity. Treat insomnia aggressively.
🚢
Moderate exercise
Walking, yoga, swimming β€” fine. Avoid intense cardio while tachycardic & untreated.
πŸ‹οΈ
Resistance training
Counteracts muscle wasting & bone loss once heart rate is controlled.
πŸ₯—
Anti-inflammatory diet
Mediterranean: vegetables, olive oil, fish, nuts, berries. Reduce ultra-processed.
🌾
Gluten-free if celiac+
Celiac ~4Γ— more common with Graves'. Test; if positive, strict GF improves outcomes.
πŸ•ΆοΈ
Eye care for ophthalmopathy
Artificial tears, sleep with head elevated, sunglasses outdoors, cool compresses.
🌑️
Cool environment
Helps heat intolerance & sleep while hyperthyroid.
What to avoid / be careful with β€” show all
πŸ§‚
Excess iodine
Kelp, seaweed snacks, iodine supplements, iodine-rich cough syrups can trigger or worsen Graves'.
🚬
Smoking
Strongest modifiable risk factor for Graves' ophthalmopathy. Quitting can halve eye disease progression.
β˜•
High caffeine
Amplifies tachycardia, tremor, insomnia. Limit during active disease.
🍷
Alcohol
Worsens sleep & bone loss; can interact with ATDs.
🌿
"Thyroid support" blends
Often contain undeclared iodine, ashwagandha, or thyroid extract β€” can destabilize you.
🌱
Excess soy
Can interfere with levothyroxine absorption post-treatment. Normal dietary amounts are fine.

Download all datasets

Eight sources, mixed access. Summary first; expand any row for the command-line recipe.

Dataset summary

SourceTypeHas age / sexAccessLink
UCI Thyroid DiseaseClinical labs + DxYesOpenarchive.ics.uci.edu
NHANES (CDC)Survey + labsYesOpenwwwn.cdc.gov
Kaggle thyroid setsVarious clinicalYesFree accountkaggle.com
NCBI GEOGene expressionPer studyOpenncbi.nlm.nih.gov/gds
UK BiobankPopulation cohortYesApplication + feeukbiobank.ac.uk
ClinicalTrials.govTrial registryYes (aggregate)Open APIclinicaltrials.gov
ImmPortImmunology studiesYesFree accountimmport.org
dbGaPGenotype + phenotypeYesdbGaP authorizationncbi.nlm.nih.gov/gap

Command-line recipes

UCI Thyroid DiseaseNo login

Already downloaded into ./datasets/. To redo from scratch:

# bash
mkdir -p datasets && cd datasets
BASE=https://archive.ics.uci.edu/ml/machine-learning-databases/thyroid-disease
for f in allhyper allbp sick-euthyroid hypothyroid sick allhypo; do
  curl -sSLO $BASE/$f.data
  curl -sSLO $BASE/$f.names 2>/dev/null
done
# index of all files
curl -s $BASE/ | grep -oE 'href="[^"]+"' | head -40
NHANES (CDC)No login

Official US health survey. Files are SAS XPT format; needs pyreadstat or haven to read.

# 2007-2008 thyroid module (TSH, T4, antibodies)
mkdir -p datasets/nhanes && cd datasets/nhanes
curl -sSLO https://wwwn.cdc.gov/Nchs/Nhanes/2007-2008/THYROD_E.XPT
curl -sSLO https://wwwn.cdc.gov/Nchs/Nhanes/2007-2008/DEMO_E.XPT

# Python read
python3 -c "
import pyreadstat
df,_ = pyreadstat.read_xport('THYROD_E.XPT')
print(df.columns.tolist()[:15])
print(df.head())"

Cycle index: wwwn.cdc.gov/nchs/nhanes β€” pick a year & component (Laboratory β†’ Thyroid).

Kaggle thyroid datasetsFree account + API key

One-time setup, then scriptable:

# 1. install CLI
pip install kaggle

# 2. get API token at https://www.kaggle.com/settings β†’ Create API Token
#    saves kaggle.json β€” move it:
mkdir -p ~/.kaggle && mv ~/Downloads/kaggle.json ~/.kaggle/
chmod 600 ~/.kaggle/kaggle.json

# 3. download
cd datasets
kaggle datasets download -d emmanuelfwerr/thyroid-disease-data
kaggle datasets download -d yasserhessein/thyroid-disease-data-set
kaggle datasets download -d nguyenvy/nhanes-19882018
unzip -o "*.zip"
NCBI GEO β€” gene expressionOpen

Search hits include datasets like GSE9340 (Graves' thyroid tissue) and GSE71956 (orbital tissue).

# Example: download a GEO series matrix
mkdir -p datasets/geo && cd datasets/geo
ACC=GSE9340
curl -sSLO "https://ftp.ncbi.nlm.nih.gov/geo/series/${ACC:0:5}nnn/$ACC/matrix/${ACC}_series_matrix.txt.gz"
gunzip -f ${ACC}_series_matrix.txt.gz

# Python alternative with GEOparse
pip install GEOparse
python3 -c "
import GEOparse
g = GEOparse.get_GEO('GSE9340', destdir='./')
print(g.metadata.get('summary'))"

Browse studies: GEO search "graves disease".

UK BiobankApplication + fee

Best for population-scale work, but not a same-day download.

  1. Register at ukbiobank.ac.uk as a researcher.
  2. Submit an Access Management System (AMS) application describing your project (~6–8 weeks review).
  3. Pay access fee (currently Β£3,000–9,000 depending on data scope).
  4. Download via the UKB Research Analysis Platform (cloud) or bulk files for approved fields. Thyroid-relevant fields: 20002 (self-reported diagnosis), ICD codes E05.x (hyperthyroid), serum TSH/FT4.
ClinicalTrials.govOpen API

Bulk-download summary results for all Graves' trials:

# JSON API β€” no login
curl -sSL "https://clinicaltrials.gov/api/v2/studies?query.cond=Graves+Disease&pageSize=100" \
  -o datasets/clinicaltrials_graves.json
python3 -c "
import json
d = json.load(open('datasets/clinicaltrials_graves.json'))
print('Studies:', len(d['studies']))
for s in d['studies'][:5]:
    print('-', s['protocolSection']['identificationModule']['briefTitle'])"
ImmPort β€” immunology studiesFree account

Has several thyroid autoimmunity studies. Register at immport.org, then use their Aspera client or the web download for studies tagged "Graves' disease".

Sources

Patient resources, clinical guidelines, and the research papers behind the numbers on this page.